TY - JOUR T1 - Management of Temporomandibular Joint Arthritis in JIA: Tradition-based or Evidence-based? JF - The Journal of Rheumatology JO - J Rheumatol SP - 1205 LP - 1207 DO - 10.3899/jrheum.180363 VL - 45 IS - 9 AU - PETER STOUSTRUP AU - MARINKA TWILT AU - CORY M. RESNICK Y1 - 2018/09/01 UR - http://www.jrheum.org/content/45/9/1205.abstract N2 - Only a decade ago, the temporomandibular joint (TMJ) was referred to as “the forgotten joint in juvenile idiopathic arthritis (JIA)” owing to a lack of clinical and research attention1. More recently, with the finding that TMJ arthritis is seen in a majority of patients with JIA2, an increasing amount of research has focused on this joint. TMJ arthritis may cause pain, impair joint and masticatory function, and affect dentofacial growth, leading to facial asymmetry and bite disturbances. TMJ destruction from arthritis significantly harms oral health and general quality of life3.Despite progress in research, strategies for management of TMJ arthritis are still based primarily on conviction and tradition rather than science. Systemic therapy is frequently ineffective in controlling TMJ disease4. By tradition, local management with intraarticular corticosteroid injection (IACI) is a common backup plan5,6. This has evolved from the decades-long effective use of IACI in management of adult temporomandibular disorder7. In early translation of this technique to children with JIA, it was found to be safe and effective8. IACI improves TMJ/mandibular function and provides pain relief for patients with JIA9. Further study, however, has found that the clinical benefits of IACI usually dissipate within the … Address correspondence to Dr. P. Stoustrup, Vennelyst Blvd. 9-11, 8000 Aarhus C, Denmark. E-mail: pstoustrup{at}odont.au.dk ER -